Biomarkers For Identifying Patient Classes

Abstract

Disclosed are methods for classifying a patient with cancer as a candidate for therapy with a Bcl-2 family inhibitor comprising determining the level of at least one biomarker in a sample and comparing the biomarker level to a threshold level. Also described are methods for identifying classes of patients having a refractory cancer for second-line therapy comprising a Bcl-2 family inhibitor, where the method comprises determining the level of at least one biomarker in a sample and comparing the biomarker level to a threshold level.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 12, 2012
  • Application: Dec 6, 2011
    US US 201113311752 A
  • Priority: Dec 6, 2011
    US US 201113311752 A
  • Priority: Dec 1, 2011
    US US 201113309307 A
  • Priority: Dec 28, 2006
    US US 64710306 A
  • Priority: Sep 5, 2006
    US US 84230406 P

Download Citation


Sign in to the Lens

Feedback